fda statement bpc-157 compounding safety risks BIG NEWS FOR BPC 157 Today, the FDA's Pharmacy Advisory Committee voted 8 to 6 to recommend adding BPC 157 to the list of substances that may be eligible for pharmacy The FDA is reviewing which

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW Survey: Half of Peptide Users Aren't Aware of FDA Approval Status Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies.

SKU: 78993072415 · From mlbdaktechniek.nl